These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24663806)

  • 41. Radiolabeling and in vitro and in vivo evaluation of [18F]-FE-DABP688 as a PET radioligand for the metabotropic glutamate receptor subtype 5.
    Honer M; Stoffel A; Kessler LJ; Schubiger PA; Ametamey SM
    Nucl Med Biol; 2007 Nov; 34(8):973-80. PubMed ID: 17998101
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Imaging in vivo glutamate fluctuations with [(11)C]ABP688: a GLT-1 challenge with ceftriaxone.
    Zimmer ER; Parent MJ; Leuzy A; Aliaga A; Aliaga A; Moquin L; Schirrmacher ES; Soucy JP; Skelin I; Gratton A; Gauthier S; Rosa-Neto P
    J Cereb Blood Flow Metab; 2015 Jul; 35(7):1169-74. PubMed ID: 25806702
    [TBL] [Abstract][Full Text] [Related]  

  • 43. mGluR5 receptor availability is associated with lower levels of negative symptoms and better cognition in male patients with chronic schizophrenia.
    Régio Brambilla C; Veselinović T; Rajkumar R; Mauler J; Orth L; Ruch A; Ramkiran S; Heekeren K; Kawohl W; Wyss C; Kops ER; Scheins J; Tellmann L; Boers F; Neumaier B; Ermert J; Herzog H; Langen KJ; Jon Shah N; Lerche C; Neuner I
    Hum Brain Mapp; 2020 Jul; 41(10):2762-2781. PubMed ID: 32150317
    [TBL] [Abstract][Full Text] [Related]  

  • 44. mGluR5 binding changes during a mismatch negativity task in a multimodal protocol with [
    Régio Brambilla C; Veselinović T; Rajkumar R; Mauler J; Matusch A; Ruch A; Orth L; Ramkiran S; Sbaihat H; Kaulen N; Khudeish NY; Wyss C; Heekeren K; Kawohl W; Rota Kops E; Tellmann L; Scheins J; Boers F; Neumaier B; Ermert J; Lang M; Stüsgen S; Herzog H; Langen KJ; Shah NJ; Lerche CW; Neuner I
    Transl Psychiatry; 2022 Jan; 12(1):6. PubMed ID: 35013095
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vivo positron emission tomography imaging with [¹¹C]ABP688: binding variability and specificity for the metabotropic glutamate receptor subtype 5 in baboons.
    DeLorenzo C; Milak MS; Brennan KG; Kumar JS; Mann JJ; Parsey RV
    Eur J Nucl Med Mol Imaging; 2011 Jun; 38(6):1083-94. PubMed ID: 21279350
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis, radiolabeling, in vitro and in vivo evaluation of [18F]-FPECMO as a positron emission tomography radioligand for imaging the metabotropic glutamate receptor subtype 5.
    Lucatelli C; Honer M; Salazar JF; Ross TL; Schubiger PA; Ametamey SM
    Nucl Med Biol; 2009 Aug; 36(6):613-22. PubMed ID: 19647167
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro and in vivo evaluation of [18F]-FDEGPECO as a PET tracer for imaging the metabotropic glutamate receptor subtype 5 (mGluR5).
    Wanger-Baumann CA; Mu L; Honer M; Belli S; Alf MF; Schubiger PA; Krämer SD; Ametamey SM
    Neuroimage; 2011 Jun; 56(3):984-91. PubMed ID: 21406237
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Imaging glutamate homeostasis in cocaine addiction with the metabotropic glutamate receptor 5 positron emission tomography radiotracer [(11)C]ABP688 and magnetic resonance spectroscopy.
    Martinez D; Slifstein M; Nabulsi N; Grassetti A; Urban NB; Perez A; Liu F; Lin SF; Ropchan J; Mao X; Kegeles LS; Shungu DC; Carson RE; Huang Y
    Biol Psychiatry; 2014 Jan; 75(2):165-71. PubMed ID: 24035345
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regional brain mGlu5 receptor occupancy following single oral doses of mavoglurant as measured by [
    Streffer J; Treyer V; Buck A; Ametamey SM; Blagoev M; Maguire RP; Gautier A; Auberson YP; Schmidt ME; Vranesic IT; Gomez-Mancilla B; Gasparini F
    Neuroimage; 2021 Apr; 230():117785. PubMed ID: 33545349
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preclinical Evaluation and Quantification of 18F-FPEB as a Radioligand for PET Imaging of the Metabotropic Glutamate Receptor 5.
    de Laat B; Leurquin-Sterk G; Celen S; Bormans G; Koole M; Van Laere K; Casteels C
    J Nucl Med; 2015 Dec; 56(12):1954-9. PubMed ID: 26405172
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Marked global reduction in mGluR5 receptor binding in smokers and ex-smokers determined by [11C]ABP688 positron emission tomography.
    Akkus F; Ametamey SM; Treyer V; Burger C; Johayem A; Umbricht D; Gomez Mancilla B; Sovago J; Buck A; Hasler G
    Proc Natl Acad Sci U S A; 2013 Jan; 110(2):737-42. PubMed ID: 23248277
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential paired-pulse responses between the CA1 region and the dentate gyrus are related to altered CLC-2 immunoreactivity in the pilocarpine-induced rat epilepsy model.
    Kwak SE; Kim JE; Kim DS; Won MH; Lee HJ; Choi SY; Kwon OS; Kim JS; Kang TC
    Brain Res; 2006 Oct; 1115(1):162-8. PubMed ID: 16930566
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Smoking but not cocaine use is associated with lower cerebral metabotropic glutamate receptor 5 density in humans.
    Hulka LM; Treyer V; Scheidegger M; Preller KH; Vonmoos M; Baumgartner MR; Johayem A; Ametamey SM; Buck A; Seifritz E; Quednow BB
    Mol Psychiatry; 2014 May; 19(5):625-32. PubMed ID: 23628984
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PET imaging of mGluR5 in Alzheimer's disease.
    Mecca AP; McDonald JW; Michalak HR; Godek TA; Harris JE; Pugh EA; Kemp EC; Chen MK; Salardini A; Nabulsi NB; Lim K; Huang Y; Carson RE; Strittmatter SM; van Dyck CH
    Alzheimers Res Ther; 2020 Jan; 12(1):15. PubMed ID: 31954399
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The lesional and epileptogenic consequences of lithium-pilocarpine-induced status epilepticus are affected by previous exposure to isolated seizures: effects of amygdala kindling and maximal electroshocks.
    André V; Ferrandon A; Marescaux C; Nehlig A
    Neuroscience; 2000; 99(3):469-81. PubMed ID: 11029539
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quantitative positron emission tomography of mGluR5 in rat brain with [(18) F]PSS232 at minimal invasiveness and reduced model complexity.
    Müller Herde A; Keller C; Milicevic Sephton S; Mu L; Schibli R; Ametamey SM; Krämer SD
    J Neurochem; 2015 May; 133(3):330-42. PubMed ID: 25439096
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dantrolene inhibits the calcium plateau and prevents the development of spontaneous recurrent epileptiform discharges following in vitro status epilepticus.
    Nagarkatti N; Deshpande LS; Carter DS; DeLorenzo RJ
    Eur J Neurosci; 2010 Jul; 32(1):80-8. PubMed ID: 20597971
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vigabatrin protects against hippocampal damage but is not antiepileptogenic in the lithium-pilocarpine model of temporal lobe epilepsy.
    André V; Ferrandon A; Marescaux C; Nehlig A
    Epilepsy Res; 2001 Nov; 47(1-2):99-117. PubMed ID: 11673025
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pilocarpine-induced status epilepticus increases Homer1a and changes mGluR5 expression.
    Cavarsan CF; Tescarollo F; Tesone-Coelho C; Morais RL; Motta FL; Blanco MM; Mello LE
    Epilepsy Res; 2012 Sep; 101(3):253-60. PubMed ID: 22591751
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Measuring the effects of ketamine on mGluR5 using [
    Holmes SE; Gallezot JD; Davis MT; DellaGioia N; Matuskey D; Nabulsi N; Krystal JH; Javitch JA; DeLorenzo C; Carson RE; Esterlis I
    J Cereb Blood Flow Metab; 2020 Nov; 40(11):2254-2264. PubMed ID: 31744389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.